Goyal, MD, MPH, MBA, FAAFP, FACPM Gerald (Jud) DeLoss Beena Peters, DNP, RN, FACHE, FABC,FAAN Ian Jasenof, MD, FACOG, MHA, CPE Deborah J Hodges Courtney Avery, MPH Dawn V
GLP-1 (Glucagon-Like Peptide-1) receptor agonists are medications originally developed to treat type 2 diabetes
Medical examinations revealed extensive damage to the retinal blood vessels, causing blindness
People are nuts about protein and likely beyond this claim, nobody cares what other nutritional attributes ...they're just "noise" (or a layered on health halo)
Patients with type 2 diabetes and obesitythe primary populations receiving tirzepatidehave multiple independent risk factors for acute pancreatitis that exist regardless of medication use
Wegovy is a 'name-brand' form of semaglutide, a type of medication called a glucagon-like peptide 1 receptor agonist, better known as a GLP-1. Semaglutide the active ingredient in Wegovy works by mimicking the GLP-1 hormones that are naturally secreted by the intestine after a meal